<DOC>
	<DOCNO>NCT01117792</DOCNO>
	<brief_summary>The primary objective evaluate S-ICD system 's ability identify terminate induce ventricular fibrillation patient implant procedure . The safety performance S-ICD system also assess throughout patient follow-up period .</brief_summary>
	<brief_title>Subcutaneous Implantable Defibrillator ( S-ICD ) System - CE Clinical Investigation</brief_title>
	<detailed_description />
	<criteria>Replacement exist implant transvenous ICD system Class I , Class IIa , Class IIb ACC/AHA/HRS indication patient without exist transvenous ICD system Age &gt; = 18 year Appropriate preoperative ECG measure specially developed template Subjects unable unwilling provide inform consent Any condition precludes subject 's ability comply study requirement Females pregnant lactate premenopausal woman unwilling use adequate birth control duration study Participation another investigational device trial time conduct SICD system trial without write consent sponsor . Patients serious medical condition life expectancy le one year . Patients document spontaneous frequently recur VT reliably terminate antitachycardia pacing Patients exist epicardial patch subcutaneous electrode leave thoracic quadrant Patients impaired kidney function measure CockcroftGault Glomerular Filtration Rate ( GFR ) GFR &lt; = 29 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>